Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis

PLoS Computational Biology

Volumn 7, Issue 10, 2011, Pages

  Mitchell, Kate M ^a,b   Mutapi, Francisca ^a   Savill, Nicholas J ^a   Woolhouse, Mark E J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; LIFE CYCLE; MODEL STRUCTURES;

AGE-RELATED; ANTIBODIES RESPONSE; CROSS REGULATION; DETERMINISTIC MODELING; FIELD DATA; PEAK SHIFT; PROTECTIVE IMMUNITIES; SHIFT-AND; SUB-SAHARAN AFRICA; TROPICAL DISEASE;

ANTIBODIES;

AFRICA; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; LARVAL STAGE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEMORY CELL; NONHUMAN; PERCEPTIVE THRESHOLD; PLASMA CELL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; TREMATODE LIFE CYCLE STAGE; UROGENITAL TRACT INFECTION; ADOLESCENT; ADULT; AGE; BIOLOGICAL MODEL; BLOOD; CHILD; HUMAN; IMMUNOLOGY; PARASITOLOGY; SCHISTOSOMIASIS HAEMATOBIA;

SCHISTOSOMA;

HELMINTH ANTIBODY; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; HUMANS; MODELS, IMMUNOLOGICAL; SCHISTOSOMIASIS HAEMATOBIA; YOUNG ADULT;

EID: 80055076206     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002237     Document Type: Article

References (63)

1. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
2. van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
3. Jordan P, Webbe G, Sturrock RF, (1993) Human Schistosomiasis Wallingford CAB International.
4. Mott KE, (1983) A reusable polyamide filter for diagnosis of S. hematobium infection by urine filtration. Bull Soc Pathol Exot 76: 101-104.
5. Fulford AJC, Butterworth AE, Ouma JH, Sturrock RF, (1995) A statistical approach to schistosome population-dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology 110: 307-316.
6. Wilkins HA, Goll PH, de C. Marshall TF, Moore PJ, (1984) Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection. Trans R Soc Trop Med Hyg 78: 227-232.
7. Clarke V de V, (1966) The influence of acquired resistance in the epidemiology of bilharziasis. Cent Afr J Med 12: 1-30.
8. Wilkins HA, Blumenthal UJ, Hagan P, Hayes RJ, Tulloch S, (1987) Resistance to reinfection after treatment of urinary schistosomiasis. Trans R Soc Trop Med Hyg 81: 29-35.
9. Chandiwana SK, Taylor P, Clarke VD, (1988) Prevalence and intensity of schistosomiasis in 2 rural areas in Zimbabwe and their relationship to village location and snail infection rates. Ann Trop Med Parasit 82: 163-173.
10. Woolhouse MEJ, (1998) Patterns in parasite epidemiology: the peak shift. Parasitol Today 14: 428-434.
11. Woolhouse MEJ, (1992) A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol 14: 563-578.
12. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse MEJ, (1997) A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol 19: 255-263.
13. Ndhlovu P, Cadman H, Vennervald BJ, Christensen NO, Chidimu M, et al. (1996) Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol 18: 181-191.
14. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA, (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.
15. Woolhouse MEJ, Mutapi F, Ndhlovu PD, Chandiwana SK, Hagan P, (2000) Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology 120: 37-44.
16. Mutapi F, Ndhlovu PD, Hagan P, Spicer JT, Mduluza T, et al. (1998) Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 178: 289-293.
17. Woolhouse MEJ, Hagan P, (1999) Seeking the ghost of worms past. Nat Med 5: 1225-1227.
18. Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CMR, et al. (2008) Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 198: 167-175.
19. Anderson RM, May RM, (1985) Herd-immunity to helminth infection and implications for parasite control. Nature 315: 493-496.
20. Mitchell KM, Mutapi F, Woolhouse MEJ, (2008) The predicted impact of immunosuppression upon population age-intensity profiles for schistosomiasis. Parasite Immunol 30: 462-470.
21. Fulford AJC, Butterworth AE, Sturrock RF, Ouma JH, (1992) On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 105: 219-227.
22. Duerr HP, Dietz K, Eichner M, (2003) On the interpretation of age-intensity profiles and dispersion patterns in parasitological surveys. Parasitology 126: 87-101.
23. Grimm V, Revilla E, Berger U, Jeltsch F, Mooij WM, et al. (2005) Pattern-oriented modeling of agent-based complex systems: lessons from ecology. Science 310: 987-991.
24. Wiegand K, Saltz D, Ward D, Levin SA, (2008) The role of size inequality in self-thinning: a pattern-oriented simulation model for arid savannas. Ecol Model 210: 431-445.
25. Swanack TM, Grant WE, Forstner MRJ, (2009) Projecting population trends of endangered amphibian species in the face of uncertainty: a pattern-oriented approach. Ecol Model 220: 148-159.
26. Rossmanith E, Blaum N, Grimm V, Jeltsch F, (2007) Pattern-oriented modelling for estimating unknown pre-breeding survival rates: the case of the Lesser Spotted Woodpecker (Picoides minor). Biol Conserv 135: 555-564.
27. Jenkins SJ, Hewitson JP, Jenkins GR, Mountford AP, (2005) Modulation of the host's immune response by schistosome larvae. Parasite Immunol 27: 385-393.
28. Pearce EJ, (2005) Priming of the immune response by schistosome eggs. Parasite Immunol 27: 265-270.
29. Skelly PJ, Wilson RA, (2006) Making sense of the schistosome surface. Adv Parasit 63: 185-284.
30. Smithers SR, Terry RJ, Hockley DJ, (1969) Host antigens in schistosomiasis. Proc R Soc Lond B Biol Sci 171: 483-494.
31. Abbas AK, Murphy KM, Sher A, (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793.
32. Jeannin P, Lecoanet S, Delneste Y, Gauchat J-F, Bonnefoy J-Y, (1998) IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 160: 3555-3561.
33. Woolhouse MEJ, Taylor P, Matanhire D, Chandiwana SK, (1991) Acquired immunity and epidemiology of Schistosoma haematobium. Nature 351: 757-759.
34. Goddard MJ, Jordan P, (1980) On the longevity of Schistosoma mansoni in man on St. Lucia, West Indies. Trans R Soc Trop Med Hyg 74: 185-191.
35. Vermund SH, Bradley DJ, Ruiztiben E, (1983) Survival of Schistosoma mansoni in the human host-estimates from a community-based prospective study in Puerto Rico. Am J Trop Med Hyg 32: 1040-1048.
36. Milner T, Reilly L, Nausch N, Midzi N, Mduluza T, et al. (2010) Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol 32: 710-721.
37. Mutapi F, Winborn G, Midzi N, Taylor M, Mduluza T, et al. (2007) Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age. BMC Infect Dis 7: 139.
38. Mutapi F, Rujeni N, Bourke C, Mitchell KM, Nausch N, et al. (2011) Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 5: e1143.
39. Chan MS, Mutapi F, Woolhouse MEJ, Isham VS, (2000) Stochastic simulation and the detection of immunity to schistosome infections. Parasitology 120: 161-169.
40. Woolhouse MEJ, (1993) A theoretical framework for immune responses and predisposition to helminth infection. Parasite Immunol 15: 583-594.
41. Wilson JN, Nokes DJ, (1999) Do we need 3 doses of hepatitis B vaccine? Vaccine 17: 2667-2673.
42. Wilson JN, Nokes DJ, Medley GF, Shouval D, (2007) Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules. Vaccine 25: 3705-3712.
43. Morell A, Terry WD, Waldmann TA, (1970) Metabolic properties of IgG subclasses in man. J Clin Invest 49: 673-680.
44. Waldmann TA, Strober W, (1969) Metabolism of immunoglobulins. Prog Allergy 13: 1-110.
45. Woolhouse MEJ, (1994) A theoretical framework for the immunoepidemiology of blocking antibodies to helminth infection. Parasite Immunol 16: 415-424.
46. Press W, Teukolsky S, Vetterling W, Flannery B, (2002) Numerical recipes in C++: the art of scientific computing Cambridge University Press.
47. Pickles M, Foss AM, Vickerman P, Deering K, Verma S, et al. (2010) Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect 86: I33-I43.
48. Gray D, (2002) A role for antigen in the maintenance of immunological memory. Nat Rev Immunol 2: 60-65.
49. Kalia V, Sarkar S, Gourley TS, Rouse BT, Ahmed R, (2006) Differentiation of memory B and T cells. Curr Opin Immunol 18: 255-264.
50. Ochsenbein AF, Pinschewer DD, Sierro S, Horvath E, Hengartner H, et al. (2000) Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 97: 13263-13268.
51. Gambhir M, Basáñez M-G, Turner F, Kumaresan J, Grassly NC, (2007) Trachoma: transmission, infection, and control. Lancet Infect Dis 7: 420-427.
52. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGC, et al. (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6: 741-750.
53. Amanna IJ, Carlson NE, Slifka MK, (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357: 1903-1915.
54. Chandiwana SK, (1987) Community water-contact patterns and the transmission of Schistosoma haematobium in the highveld region of Zimbabwe. Soc Sci Med 25: 495-505.
55. Chandiwana SK, Woolhouse ME, (1991) Heterogeneities in water contact patterns and the epidemiology of Schistosoma haematobium. Parasitology 103: 363-370.
56. Chan MS, Isham VS, (1998) A stochastic model of schistosomiasis immuno-epidemiology. Math Biosci 151: 179-198.
57. Curwen RS, Ashton PD, Johnston DA, Wilson RA, (2004) The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasit 138: 57-66.
58. Fitzsimmons CM, McBeath R, Joseph S, Jones FM, Walter K, et al. (2007) Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: molecular structure and patterns of in vivo exposure. Int Arch Allergy Imm 142: 40-50.
59. Macallan DC, Wallace DL, Zhang Y, Ghattas H, Asquith B, et al. (2005) B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105: 3633-3640.
60. Bradley DJ, McCullough FS, (1973) Egg output stability and the epidemiology of Schistosoma haematobium Part II. An analysis of the epidemiology of endemic S. haematobium. Trans R Soc Trop Med Hyg 67: 491-500.
61. Useh MF, Ejezie GC, (1999) Modification of behaviour and attitude in the control of schistosomiasis. 1. Observations on water-contact patterns and perception of infection. Ann Trop Med Parasitol 93: 711-720.
62. Agnew A, Fulford AJ, Mwanje MT, Gachuhi K, Gutsmann V, et al. (1996) Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. Am J Trop Med Hyg 55: 338-343.
63. King CH, Muchiri EM, Ouma JH, (1992) Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations. Mem Inst Oswaldo Cruz 87 (supp. 4): 203-210.